catalyst · primary record
UPTRAVI
Patent expiry · 2026-10-31 · SELEXIPAG
| Company | ACTELION PHARMACEUTICALS US INC |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | US 7205302 expires · SELEXIPAG |
| Source | FDA Orange Book |
Provenance
- Source: FDA Orange Book
- Fetched at: 2026-10-28T10:37:15.100Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: ACTELION PHARMACEUTICALS US INC:UPTRAVI:2026-10-31:US 7205302 expires · SELEXIPAG
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.